Your Patients Need Cefepime — Here's How to Help Them Get It

When a patient needs Cefepime for a serious infection, the last thing you want to tell them is that it's unavailable. But with the ongoing Cefepime shortage stretching into 2026, this conversation is happening more often in hospitals, clinics, and infusion centers across the country.

This guide provides actionable steps you can take as a provider to help your patients access Cefepime — or transition smoothly to an effective alternative. For a clinical overview of the shortage, see our provider shortage briefing.

Current Cefepime Availability

As of March 2026, Cefepime injection remains on the ASHP drug shortage list. Key supply details:

• 2 g vials: Most frequently backordered across manufacturers
• 1 g vials: Intermittently available from multiple manufacturers
• 500 mg vials: More consistently available but less practical for standard adult dosing
• Premixed IV bags: Variable availability; some facilities report better access than with vials

Manufacturers affected include B. Braun (manufacturing delays), Baxter, Apotex, Hospira/Pfizer, and Eugia/Aurobindo. Supply levels fluctuate weekly and vary by distributor and region.

Why Patients Can't Find Cefepime

Understanding the barriers your patients face helps you guide them effectively:

• Hospital allocation limits: Many hospitals are rationing Cefepime stock, which means outpatient orders may be deprioritized
• Home infusion challenges: Patients receiving outpatient parenteral antibiotic therapy (OPAT) rely on specialty pharmacies, which may have different supply constraints than hospital pharmacies
• Formulation mismatches: A patient's prescription may specify a particular vial size that's out of stock, even when other sizes are available
• Geographic variation: Supply levels differ significantly by region; a facility across town may have stock when the patient's usual pharmacy doesn't
• Cost barriers: Uninsured patients or those in high-deductible plans may face cash prices of $90-$400+ for a treatment course

What Providers Can Do: 5 Actionable Steps

Step 1: Check Real-Time Availability on Medfinder

Medfinder for Providers tracks Cefepime availability across pharmacies, distributors, and suppliers in real time. Before changing a patient's treatment plan, check whether the medication is available at another facility. A two-minute search can save your patient a medication change.

Step 2: Be Flexible on Formulation

If the 2 g vials are out of stock, consider whether using two 1 g vials is feasible for the patient's treatment setting. Similarly, premixed IV bags may be available when reconstitution vials are not. Adjust prescriptions to match what's available without compromising clinical efficacy.

Step 3: Engage Your Institution's Shortage Committee

Most hospitals and health systems have drug shortage management teams that:

• Monitor supply levels and manufacturer updates
• Develop therapeutic interchange protocols
• Allocate limited stock based on clinical priority
• Coordinate with group purchasing organizations (GPOs) for additional sourcing

If your patient's case is urgent, escalating through the shortage committee can unlock access to reserved stock or expedite sourcing from alternative distributors.

Step 4: Consider Appropriate Alternatives

When Cefepime genuinely cannot be sourced, the following alternatives may be appropriate:

• Ceftazidime: Closest pharmacologic substitute; 1-2 g IV every 8 hours; anti-Pseudomonal activity; note reduced gram-positive coverage vs. Cefepime
• Piperacillin/Tazobactam (Zosyn): 3.375-4.5 g IV every 6-8 hours; broader anaerobic coverage; commonly used for intra-abdominal infections
• Meropenem: 1-2 g IV every 8 hours; broadest spectrum; reserve for resistant organisms or critically ill patients
• Ceftazidime/Avibactam (Avycaz): 2.5 g IV every 8 hours; for ESBL/AmpC-producing organisms; higher cost

See our detailed alternatives guide for clinical comparison.

Step 5: Help Patients Navigate Cost Barriers

For patients facing financial barriers alongside the shortage:

• Refer to NeedyMeds (needymeds.org) and RxAssist (rxassist.org) for patient assistance programs
• Check if your institution's charity care program can cover the medication cost
• Recommend discount cards — SingleCare offers Cefepime at approximately $93 for 9 x 2 g vials vs. the ~$363 cash price
• Ensure insurance authorization is in place, especially if switching to an alternative antibiotic

For comprehensive cost-saving strategies, see our guide to helping patients save on Cefepime.

Alternatives: Clinical Considerations

Choosing the right alternative requires evaluating:

• Infection type and site: Ceftazidime is often preferred for UTIs and pneumonia; Zosyn for intra-abdominal infections with anaerobic involvement
• Culture and susceptibility data: Always review when available; avoid empiric escalation when narrower agents are effective
• Patient factors: Renal function (all alternatives require dose adjustment), allergy history (cross-reactivity between cephalosporins and penicillins is approximately 1-2%), and prior adverse reactions
• Stewardship considerations: Avoid carbapenem overuse when equally effective alternatives are available

Document the reason for the alternative selection (drug shortage) in the patient's chart for stewardship tracking and insurance purposes.

Workflow Tips for Managing the Shortage

• Set up shortage alerts: Subscribe to ASHP drug shortage notifications and your GPO's supply updates to stay ahead of availability changes
• Standardize interchange protocols: Work with your P&T committee to pre-approve therapeutic substitutions for Cefepime, reducing delays when the drug is unavailable
• Communicate proactively: When you know supply is low, discuss alternatives with patients before they arrive for treatment — not when they're already at the infusion center
• Track your switches: Monitor outcomes of patients switched from Cefepime to alternatives to ensure equivalent clinical results
• Use Medfinder regularly: Bookmark medfinder.com/providers for quick availability checks during clinical workflow

Final Thoughts

The Cefepime shortage is a systems-level problem, but the impact is felt at the individual patient level. As a provider, you have the tools and expertise to navigate this challenge — by sourcing creatively, choosing alternatives wisely, and communicating transparently with patients about their options.

Use Medfinder for Providers to check availability before making treatment changes. And when you do need to switch, document the shortage as the reason and ensure patients understand the rationale for their new treatment plan.

For patient-facing resources to share, see our patient guide to finding Cefepime and shortage update for patients.